Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Thromboembolism 1Spinal Cord Neoplasms 1Respiratory Insufficiency 1Pneumonia 1Osteosarcoma 1Myocardial Infarction 1Lung Neoplasms 1Bone Neoplasms 1Arrhythmias, Cardiac 1Angina, Unstable 1Acute Coronary Syndrome 1

Interventions

Carboplatin 340Cisplatin 238Paclitaxel 203Radiotherapy 195Pemetrexed 187Docetaxel 169Gemcitabine 157pembrolizumab 141Erlotinib Hydrochloride 107Etoposide 99Magnetic Resonance Spectroscopy 93Bevacizumab 91Specimen Handling 76Nivolumab 73Radiosurgery 72durvalumab 69Vinorelbine 54osimertinib 53Gefitinib 49Drug Therapy 49atezolizumab 42Irinotecan 42Radiation 40Topotecan 39Biopsy 39Standard of Care 38Cyclophosphamide 38Cetuximab 35Blood Specimen Collection 33Taxes 32

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Lung Neoplasms × Fluoridation × Clear all
NCT01370278 2023-08-25

Clearance Of Mucus In Stents (COMIS)

M.D. Anderson Cancer Center

Phase NA Completed
43 enrolled
Thoracic

Angina, Unstable, Arrhythmias, Cardiac, Lung Neoplasms, Myocardial Infarction, Pneumonia, Respiratory Insufficiency, Thromboembolism, Acute Coronary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡